4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-025177
Chief Medical Officer acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2020-04-17 | Option exercise | +8,000 | $0.86 | $6,840 | 15,777 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2020-04-17 | Option exercise · Employee Stock Option (Right to Buy) | −8,000 | 95,333 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…